Article
Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) using patient-derived induced pluripotent stem cells (iPSC)
2022-09-12
Abstract excerpt
<h4>ABSTRACT</h4> Using induced Pluripotent Stem Cell (iPSC) technology, it is now possible to reprogram the primary leukemic cells to pluripotency and generate a major source of stem cells. To determine the feasibility of modeling global genomic instability characterizing chronic myeloid leukemia (CML) progression towards blast crisis (BC), we have used a patient-specific iPSC line that has been submitted to in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9eb93e94-d63b-5e02-b5a0-f8b3292e07c9
- DOI
- 10.1101/2022.09.09.505857
